Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Impact of fludarabine dose modification in conditioning regimen for CAR T-cell therapy

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Acute Lymphatic Leukaemia (ALL)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Guillaume Dachy

Survey on the organization and techniques of ATMP facilities by DARE-NL, EBMT, T2Evolve, and NXTGEN-HIGHTECH - a GoCART-coalition initiative

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Cellular therapies (other than DLI)

Principal investigator

Survey on ICU organization and ICU admission after haematopoietic cell transplantation with special emphasis on infectious causes

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Joanna Drozd-Sokolowska

Comparison of allogeneic hematopoietic stem cell transplantation (HCT) with CAR T-cells in relapsed and refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma (PMBCL)

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Infections following CAR-T therapy. A retrospective collaborative study between the Infectious Diseases Working Party (IDWP), the Cellular Therapy and Immunobiology Working Party (CTIWP), the Transplant Complications Working Party (TCWP) of the EBMT, the European Hematology Association (EHA), and the Medical College of Wisconsin.

Closed Survey/Study

Non-Hodgkin’s Lymphoma (NHL)

Acute Lymphatic Leukaemia (ALL)

GoCART Coalition

Infectious Diseases Working Party (IDWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Patterns and treatments of relapse after commercial use of anti-CD19 CART therapy in patients with relapsed/refractory diffuse large B cell lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Type of treatment

Principal investigator

Alberto Mussetti

Autoimmune and autoinflammatory complications after CAR-T cell therapy - a joint study on behalf of the EBMT - ADWP, CTIWP and TCWP

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Autoimmune Diseases Working Party (ADWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Impact of Preceding Therapy of CART Cells in B-ALL and impact of consolidative HCT following complete remission post CART

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

GoCART Coalition

Type of treatment

Principal investigator

Valentín ORTIZ-MALDONADO

Practice patterns of holding and bridging therapy for mantle cell lymphoma patients in the CAR T-cell setting

Closed Survey/Study

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Gloria Iacoboni, MD, PhD, Pere Barba, MD, PhD

Multicentric evaluation of CAR-T cell induced pseudoprogression prevalence (PrevCARTiPP)

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Friedrich Stoelzel

Thrombotic microangiopathy (TMA) after CAR-T cell therapy

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Guillaume Dachy

CAR-T cell outcomes in patients with comorbidities

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator